Detalhe da pesquisa
1.
Transfusion-Transmitted Cache Valley Virus Infection in a Kidney Transplant Recipient With Meningoencephalitis.
Clin Infect Dis
; 76(3): e1320-e1327, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35883256
2.
A Pilot Study of F-18 Fluciclovine-PET/CT as a Diagnostic Tool for Bone Metastases in Patients With Castrate Resistant Prostate Adenocarcinoma and Correlative Analysis of Blood and Bone Molecular Testing (The FACT Study).
Oncologist
; 28(11): e1114-e1117, 2023 Nov 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37616280
3.
A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma.
Invest New Drugs
; 40(1): 81-90, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34417914
4.
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
Invest New Drugs
; 40(1): 134-141, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34463891
5.
Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile.
Support Care Cancer
; 30(3): 2755-2766, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34825982
6.
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations.
Dig Dis Sci
; 67(8): 3797-3805, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34773565
7.
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Oncologist
; 26(9): e1508-e1513, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33942954
8.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 379(4): 341-351, 2018 07 26.
Artigo
Inglês
| MEDLINE | ID: mdl-29863979
9.
Exceptional response to cyclophosphamide and dexamethasone in a patient with metastatic castrate-resistant prostate cancer and RB1 mutation.
Anticancer Drugs
; 32(3): 337-343, 2021 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33534414
10.
Efficacy of olanzapine, neurokinin-1 receptor antagonists, and thalidomide in combination with palonosetron plus dexamethasone in preventing highly emetogenic chemotherapy-induced nausea and vomiting: a Bayesian network meta-analysis.
Support Care Cancer
; 28(3): 1031-1039, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31823054
11.
Implementation of a Low-Cost Quality Improvement Intervention Increases Adherence to Cancer Screening Guidelines and Reduces Healthcare Costs at a University Medical Center.
J Cancer Educ
; 35(5): 930-936, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31093906
12.
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
Prostate
; 79(8): 880-895, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30900310
13.
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.
Invest New Drugs
; 37(4): 636-645, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30264293
14.
Hypoxia-activated prodrugs in the treatment of advanced pancreatic adenocarcinoma.
Anticancer Drugs
; 28(2): 127-132, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27685167
15.
Phase I Study of Concomitant Pemetrexed and Cisplatin Plus External Beam Radiation Therapy in Patients with Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Carcinomas.
Cancer Invest
; 34(2): 57-63, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26810581
16.
A multicenter, open-label, Phase 1 study evaluating the safety and tolerability of pegaspargase in combination with gemcitabine in advanced metastatic solid tumors and lymphoma.
Cancer Invest
; 33(5): 172-9, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25844818
17.
An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer.
Expert Opin Pharmacother
; 25(1): 79-90, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38193476
18.
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials.
Clin Exp Gastroenterol
; 17: 121-134, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38650920
19.
APRI score is not predictive of post-surgical outcomes in cholangiocarcinoma patients.
Ann Gastroenterol
; 37(1): 95-103, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38223247
20.
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma.
Cancers (Basel)
; 16(10)2024 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38791940